Letter: tenofovir may be superior to entecavir for treatment-naive chronic hepatitis B patients

被引：2
|
作者：
Wang, Ji-Gan [1 ]
Chen, Rui [1 ]
Wang, Li-Chuan [1 ]
机构：
[1] Maternal & Child Hlth Hosp Guangxi Zhuang Autonom, Nanning, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 53卷 / 09期
关键词：
HEPATOCELLULAR-CARCINOMA; VIRAL LOAD; MORTALITY; RISK; HBV;
D O I：
10.1111/apt.16323
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1048 / 1049
页数：2
相关论文
共 50 条
  • [1] Letter: tenofovir may be superior to entecavir for treatment-naive chronic hepatitis B patients-authors' reply
    Pol, Stanislas
    Lusivika Nzinga, Clovis
    Carrat, Fabrice
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1050 - 1050
  • [2] Tenofovir is Superior to Entecavir in Patients with Treatment-naive Hepatitis B e-Antigen-Positive Chronic Hepatitis B
    Behera, Manas K.
    Pati, Girish K.
    Narayan, Jimmy
    Mishra, Debakanta
    Meher, Lalit K.
    Singh, Ayaskant
    Uthansingh, Kanishka
    Sahu, Manoj K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (01) : 37 - 44
  • [3] Tenofovir is superior to entecavir in HBeAg positive treatment Naive chronic hepatitis B Patients
    Behera, Manas Kumar
    Pati, Girish Kumar
    Singh, Ayaskant
    Narayan, Jimmy
    Sahu, Manoj Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 474 - 474
  • [4] Virologic Response and Safety of Tenofovir Versus Entecavir in Treatment-Naive Chronic Hepatitis B Patients
    Yu, Hyung Min
    Kwon, So Young
    Kim, Jiwan
    Chung, Hyun Ah
    Kwon, Se Woong
    Jeong, Taek Gun
    An, Sang Hee
    Jeong, Gyung Won
    Yun, Seon Ung
    Min, Jae Ki
    Kim, Jeong Han
    Choe, Won Hyeok
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2015, 21 (03): : 146 - 151
  • [5] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Chon, Hye Yeon
    Ahn, Sang Hoon
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Jeong-Hoon
    Sinn, Dong Hyun
    Kim, Seung Up
    HEPATOLOGY INTERNATIONAL, 2021, 15 (06) : 1328 - 1336
  • [6] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Hye Yeon Chon
    Sang Hoon Ahn
    Yoon Jun Kim
    Jung-Hwan Yoon
    Jeong-Hoon Lee
    Dong Hyun Sinn
    Seung Up Kim
    Hepatology International, 2021, 15 : 1328 - 1336
  • [7] THE EFFECTS OF ENTECAVIR, TENOFOVIR DISOPROXIL FUMARATE, AND TENOFOVIR ALAFENAMIDE ON THE PROGNOSIS OF TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B INFECTIONS
    Chon, Hye Yeon
    Chun, Ho Soo
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Sinn, Dong Hyun
    Lee, Jeong-Hoon
    Kim, Seung Up
    HEPATOLOGY, 2020, 72 : 498A - 498A
  • [8] Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naive Chronic Hepatitis B Patients in Korea
    Choi, HeeKyoung
    Seo, Gi Hyeon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (14) : 1 - 10
  • [9] Entecavir therapy for treatment-naive chronic hepatitis B patients in Taiwan
    Dai, C.
    Yeh, M.
    Huang, C.
    Huang, C.
    Hou, N.
    Hsieh, M.
    Huang, J.
    Lin, Z.
    Chen, S.
    Tsai, J.
    Yu, M.
    Chuang, W.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 : 25 - 26
  • [10] The comparison of the long-term efficacy between entecavir and tenofovir in treatment-naive chronic hepatitis B patients
    Kim, Hyoung Su
    Park, Ji Won
    Kim, Sung Eun
    Suk, Ki Tae
    Jang, Myoung Kuk
    Park, Sang Hoon
    Kim, Dong Joon
    Lee, Myung Seok
    Kim, Hak Yang
    Park, Choong Kee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 374 - 374
12345